Skip to content

Clinical trials

Hepatitis C trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Country / region: South Korea Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20081
20092
20102
20116
20126
20132
20142
20152
20164
20174
20182
20201
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Terminated2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb13
AbbVie6
Debiopharm International SA3
Gilead Sciences3
GlaxoSmithKline3
Atea Pharmaceuticals, Inc.2
Boehringer Ingelheim2
Pfizer2
Bukwang Pharmaceutical1
GeneOne Life Science, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C39
Hepatitis C, Chronic13
Acquired Immunodeficiency Syndrome3
Coinfection2
Hepatitis2
Chronic Pain1
Fibrosis1
HIV Infections1
Hepatitis B1
Liver Cirrhosis1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.